2 not yet recruiting. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Not yet recruiting 2 |
Follow Adrenocortical Hyperfunction: new trials by email Literature Review of Adrenocortical Hyperfunction trials Research Report on Adrenocortical Hyperfunction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SPIRO-First: A Pragmatic Primary Care-Embedded Pilot Trial of Renin-Guided First-Line Antihypertensive Therapy Spironolactone (drug), Candesartan 8mg, Hydrochlorothiazide (HCTZ) 25 milligrams. - Hypertension | Phase 4 | Not yet recruiting | Ottawa Hospital Research Institute | 30 | 2027-01-01 | 2026-10-14 |
| Effects of Glucocorticoid Therapy on Renal Function in Patients With PA Complicated by CKD After Adrenalectomy: A Multicenter RCT Intervention_1 - Primary Aldosteronism Due to Adrenal Hyperplasia | Phase 4 | Not yet recruiting | Ruijin Hospital | 90 | 2026-04-22 | 2026-04-30 |
Hyperaldosteronism (2) · Hypertension (1)
Adrenal Gland Diseases (2) · Endocrine System Diseases (2) · Cardiovascular Diseases (1) · Vascular Diseases (1)
Amlodipine (1) · Hydrochlorothiazide (1) · Pharmaceutical Preparations (1) · Spironolactone (1) · candesartan (1)
Ottawa Hospital Research Institute (1) · Ruijin Hospital (1)
Canada (1)
Gregory L Hundemer, MD (1) · Sharon Johnston, MD (1)